Literature DB >> 23627271

An expedient synthesis and screening for antiacetylcholinesterase activity of piperidine embedded novel pentacyclic cage compounds.

Raju Suresh Kumar, Abdulrahman I Almansour, Natarajan Arumugam, Hasnah Osman, Mohamed Ashraf Ali, Alireza Basiri, Yalda Kia1.   

Abstract

The aim of this study was to synthesize and evaluate diazapentacyclic analogs for their acetylcholinesterase (AChE) inhibitory activity. The pentacyclic analogs were synthesized by one-pot three-component domino reactions in a microwave synthesizer. Most of the compounds exhibited moderate to good AChE inhibitory activity, compound 5i showed potent inhibitory activity with IC50 1.12 ± 0.01 µM and this may provide a new lead for developing potential inhibitors for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23627271     DOI: 10.2174/157340641002140131170054

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  3 in total

1.  An expedient synthesis, acetylcholinesterase inhibitory activity, and molecular modeling study of highly functionalized hexahydro-1,6-naphthyridines.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; Alireza Basiri; Yalda Kia; Mohamed Ashraf Ali
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

2.  A facile ionic liquid promoted synthesis, cholinesterase inhibitory activity and molecular modeling study of novel highly functionalized spiropyrrolidines.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; Alireza Basiri; Yalda Kia; Mohamed Ashraf Ali; Mehvish Farooq; Vikneswaran Murugaiyah
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

3.  Design, Synthesis and In Vitro Mechanistic Investigation of Novel Hexacyclic Cage-Like Hybrid Heterocycles.

Authors:  Suresh Kumar Raju; Abdulrahman I Almansour; Arumugam Natarajan; Faruq Mohammad
Journal:  Molecules       Date:  2019-10-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.